Brief: Microba Life Sciences Secures A$14.5 Million To Drive Clinical Adoption
23/06/2025 08:28
June 23 (Reuters) - Microba Life Sciences Ltd MAP.AX: MICROBA SECURES A$14.5 MILLION TO DRIVE CLINICAL ADOPTION EXPECTED FY25 REVENUE RANGE NARROWED TO A$15.4 - A$16 MILLION Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement